74964 Federal Register / Vol. 89, No. 178 / Friday, September 13, 2024 / Notices 

The opinions and presentations 

provided during this meeting will assist 

us as we evaluate the new medical 

services and technology applications for 

FY 2026. 

II. New Technology Town Hall Meeting 

Format and Conference Call 

Information 

A. Format of the Town Hall Meeting 

As noted in section I. of this notice, 

we are required to provide for a meeting 

at which organizations representing 

hospitals, physicians, manufacturers, 

and any other interested party may 

present comments, recommendations, 

and data to the clinical staff of CMS 

concerning whether the service or 

technology represents a substantial 

clinical improvement. This meeting will 

allow for a discussion of the substantial 

clinical improvement criterion for the 

FY 2026 applications for new 

technology add-on payments. 

Information regarding the applications 

can be found on our website at http:// 

www.cms.gov/Medicare/Medicare-Feefor-Service-Payment/AcuteInpatient

PPS/newtech.html. 

The majority of the meeting will be 

reserved for presentations of comments, 

recommendations, and data from 

registered presenters. The time for each 

presentation will be approximately 10 

minutes, with additional time reserved 

for questions, and will be based on the 

number of presentations. Individuals 

who would like to present must register 

and submit their agenda item(s) via 

email to newtech@cms.hhs.gov by the 

dates specified in the DATES section of 

this notice. 

Depending on the number of 

presentations, we will determine if a 

second meeting day is necessary. The 

final schedule for the New Technology 

Town Hall meeting will be posted on 

the CMS website at http://www.cms.gov/ 

Medicare/Medicare-Fee-for-ServicePayment/AcuteInpatientPPS/ 

newtech.html by November 25, 2024 to 

inform the public of the number of days 

of the meeting. 

In addition, written comments will 

also be accepted and presented at the 

meeting if they are received via email to 

newtech@cms.hhs.gov by the date 

specified in the DATES section of this 

notice. Written comments may also be 

submitted after the meeting for our 

consideration. If the comments are to be 

considered before the publication of the 

FY 2026 IPPS/LTCH PPS proposed rule, 

the comments must be received via 

email to newtech@cms.hhs.gov by the 

date specified in the DATES section of 

this notice. 

B. Conference Call and Webinar 

Information 

As noted previously, the New 

Technology Town Hall meeting will be 

held virtually. There will be an option 

to participate in the New Technology 

Town Hall Meeting via webinar and a 

toll-free teleconference phone line. 

Information on the option to participate 

via webinar and a teleconference dial-in 

will be provided through an upcoming 

listserv/email notice to registrants and 

will appear on the final meeting agenda, 

which will be posted on the New 

Technology website at: http://

www.cms.gov/Medicare/Medicare-Feefor-Service-Payment/AcuteInpatient

PPS/newtech.html. Continue to check 

the website for updates. 

C. Disclaimer 

We cannot guarantee reliability for a 

webinar. 

III. Registration Instructions 

The Division of New Technology in 

CMS is coordinating the meeting 

registration for the New Technology 

Town Hall meeting on substantial 

clinical improvement. While there is no 

registration fee, individuals planning to 

present at the New Technology Town 

Hall meeting must register to present. 

Registration for presenters may be 

completed by sending an email to 

newtech@cms.hhs.gov, by the date 

specified in the DATES section of this 

notice. Please include the name and 

email address of the presenter(s), as well 

as address, telephone number, and the 

name of the technology for which they 

will be presenting. 

Registration for attendees not 

presenting at the meeting is not 

required. 

IV. Collection of Information 

This document does not impose 

information collection requirements, 

that is, reporting, recordkeeping, or 

third-party disclosure requirements. 

Consequently, there is no need for 

review by the Office of Management and 

Budget under the authority of the 

Paperwork Reduction Act of 1995 (44 

U.S.C. chapter 35). 

The Administrator of the Centers for 

Medicare & Medicaid Services (CMS), 

Chiquita Brooks-LaSure, having 

reviewed and approved this document, 

authorizes Chyana Woodyard, who is 

the Federal Register Liaison, to 

electronically sign this document for 

purposes of publication in the Federal 

Register. 

Chyana Woodyard, 

Federal Register Liaison, Centers for Medicare 

& Medicaid Services. 

[FR Doc. 2024–20791 Filed 9–12–24; 8:45 am] 

BILLING CODE 4120–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Administration for Children and 

Families 

[Assistance Listing Number: 93.652] 

Announcement of the Intent To Award 

a Within Scope Awarding AgencyInitiated Non-Competitive Supplement 

With Extension to the American Public 

Human Services Association for the 

Association of Administrators of the 

Interstate Compact on the Placement 

of Children (AAICPC) in Washington, 

DC 

AGENCY: Children’s Bureau (CB), 

Administration for Children and 

Families (ACF), Department of Health 

and Human Services (HHS). 

ACTION: Notice of Issuance of a within 

scope awarding agency-initiated noncompetitive supplement with extension. 

SUMMARY: The ACF, ACYF, CB, Division 

of Capacity Building announces the 

intent to award a within scope awarding 

agency-initiated non-competitive 

supplement with extension in the 

amount of up to $1,600,000, to the 

American Public Human Services 

Association for its affiliate the 

Association of Administrators of the 

Interstate Compact on the Placement of 

Children (AAICPC) in Washington, DC, 

for the further implementation and 

support nationally of the National 

Electronic Interstate Compact Enterprise 

(NEICE) system. The NEICE is an interjurisdictional electronic system to 

improve administrative efficiency in 

implementing the Interstate Compact on 

the Placement of Children (ICPC), a 

process that ensures safe and suitable 

interstate placements for children in 

foster care. 

DATES: The proposed period of 

performance is September 30, 2024, 

through September 29, 2025. 

FOR FURTHER INFORMATION CONTACT: June 

Dorn, National Adoption Specialist, 

Children’s Bureau, Division of Capacity 

Building, 330 C St. SW, Suite 3521B, 

Washington, DC 20201. Telephone: 

(202) 205–9240; Email: June.Dorn@

acf.hhs.gov. 

SUPPLEMENTARY INFORMATION: Award 

funds will support the continued 


khammond on DSKJM1Z7X2PROD with NOTICES
Federal Register / Vol. 89, No. 178 / Friday, September 13, 2024 / Notices 74965 

implementation, support, and scale up 

of the NEICE. The NEICE is a national 

electronic system for quickly and 

securely exchanging the data and 

documents required by the Interstate 

Compact on the Placement of Children 

(ICPC) to place children with foster, 

adoptive, and kinship families across 

state lines. APHSA has been the 

recipient of funding from the ACYF/CB 

for the development and national 

implementation of the NEICE since its 

inception as a pilot project funded by 

the Partnership Fund for Program 

Integrity Innovation at the Office of 

Management and Budget and 

administered by CB in November 2013. 

This 20-month pilot proved successful 

and led to a new sole source cooperative 

agreement for the expansion of the pilot 

to all 52 jurisdictions of the AAICPC 

nationwide. This funding was further 

extended and supplemented to continue 

to support the expansion of the project 

nationally with the current funding 

period expiring September 29, 2024. 

This within scope awarding agencyinitiated non-competitive supplement 

with extension is essential to allow the 

remaining states to join the system and 

to provide ongoing support and 

upgrades necessary for an electronic 

system. In addition, the Family First 

Prevention Services Act of 2018 requires 

all states to join an electronic exchange 

system by October 1, 2027, and NEICE 

is on track to support states in meeting 

this requirement. 

It is CB’s intention to provide funding 

of up to $1,600,000 beginning 

September 30, 2024. The state members 

of the AAICPC contribute annual 

membership and connection fees; 

however, these are currently not 

adequate to meet the full operational 

costs of managing the national system. 

The APHSA is well-positioned to 

continue to scale the project nationally 

and to assure the continued optimal 

maintenance of the NEICE. 

Statutory Authority: Title II, section 

203(b) of the Child Abuse Prevention 

and Treatment and Adoption Reform 

Act of 1978 (42 U.S.C. 5113(b)(3)), as 

most recently amended by CAPTA 

Reauthorization Act of 2010. 

Anthony Petruccelli, 

Senior Grants Policy Specialist, Office of 

Grants Policy, Office of Administration. 

[FR Doc. 2024–20827 Filed 9–12–24; 8:45 am] 

BILLING CODE 4184–44–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Food and Drug Administration 

[Docket No. FDA–2024–N–4057] 

General and Plastic Surgery Devices 

Panel of the Medical Devices Advisory 

Committee; Notice of Meeting; 

Establishment of Public Docket; 

Request for Comments—ProSense 

Cryoablation System 

AGENCY: Food and Drug Administration, 

HHS. 

ACTION: Notice; establishment of a 

public docket; request for comments. 

SUMMARY: The Food and Drug 

Administration (FDA) announces a 

forthcoming public advisory committee 

meeting of the General and Plastic 

Surgery Devices Panel of the Medical 

Devices Advisory Committee (the 

Committee). The general function of the 

Committee is to provide advice and 

recommendations to the Agency on 

FDA’s regulatory issues. The meeting 

will be open to the public. FDA is 

establishing a docket for public 

comment on this document. 

DATES: The meeting will be held on 

November 7, 2024, from 9 a.m. to 6 p.m. 

eastern time. 

ADDRESSES: Holiday Inn Gaithersburg, 

Two Montgomery Village Ave., 

Gaithersburg, MD 20879. The hotel’s 

telephone number is 301–948–8900. 

The hotel’s link can be found at: https:// 

www.ihg.com/holidayinn/hotels/us/en/ 

gaithersburg/wasrv/hoteldetail. 

Answers to commonly asked 

questions about FDA advisory 

committee meetings may be accessed at: 

https://www.fda.gov/Advisory

Committees/AboutAdvisoryCommittees/ 

ucm408555.htm. 

FDA is establishing a docket for 

public comment on this meeting. The 

docket number is FDA–2024–N–4057. 

The docket will close on December 9, 

2024. Please note that late, untimely 

filed comments will not be considered. 

The https://www.regulations.gov 

electronic filing system will accept 

comments until 11:59 p.m. eastern time 

at the end of December 9, 2024. 

Comments received by mail/hand 

delivery/courier (for written/paper 

submissions) will be considered timely 

if they are received on or before that 

date. 

Comments received on or before 

October 17, 2024, will be provided to 

the Committee. Comments received after 

that date will be taken into 

consideration by FDA. In the event that 

the meeting is cancelled, FDA will 

continue to evaluate any relevant 

applications or information, and 

consider any comments submitted to the 

docket, as appropriate. 

You may submit comments as 

follows: 

Electronic Submissions 

Submit electronic comments in the 

following way: 

• Federal eRulemaking Portal: 

https://www.regulations.gov. Follow the 

instructions for submitting comments. 

Comments submitted electronically, 

including attachments, to https://

www.regulations.gov will be posted to 

the docket unchanged. Because your 

comment will be made public, you are 

solely responsible for ensuring that your 

comment does not include any 

confidential information that you or a 

third party may not wish to be posted, 

such as medical information, your or 

anyone else’s Social Security number, or 

confidential business information, such 

as a manufacturing process. Please note 

that if you include your name, contact 

information, or other information that 

identifies you in the body of your 

comments, that information will be 

posted on https://www.regulations.gov. 

• If you want to submit a comment 

with confidential information that you 

do not wish to be made available to the 

public, submit the comment as a 

written/paper submission and in the 

manner detailed (see ‘‘Written/Paper 

Submissions’’ and ‘‘Instructions’’). 

Written/Paper Submissions 

Submit written/paper submissions as 

follows: 

• Mail/Hand Delivery/Courier (for 

written/paper submissions): Dockets 

Management Staff (HFA–305), Food and 

Drug Administration, 5630 Fishers 

Lane, Rm. 1061, Rockville, MD 20852. 

• For written/paper comments 

submitted to the Dockets Management 

Staff, FDA will post your comment, as 

well as any attachments, except for 

information submitted, marked and 

identified, as confidential, if submitted 

as detailed in ‘‘Instructions.’’ 

Instructions: All submissions received 

must include the Docket No. FDA– 

2024–N–4057 for ‘‘General and Plastic 

Surgery Devices Panel of the Medical 

Devices Advisory Committee; Notice of 

Meeting; Establishment of a Public 

Docket; Request for Comments.’’ 

Received comments, those filed in a 

timely manner (see ADDRESSES), will be 

placed in the docket and, except for 

those submitted as ‘‘Confidential 

Submissions,’’ publicly viewable at 

https://www.regulations.gov or at the 

Dockets Management Staff between 9 


khammond on DSKJM1Z7X2PROD with NOTICES